-
ASAM Recaps 2026 State Legislative Sessions with Mid-Year Report
The ASAM 2026 Mid-Year Report: Trends in Addiction Medicine State Legislation recaps major trends in addiction-related state policy.Full story -
ASAM Responds to HHS Request for Comment on the Chronic Disease of Addiction
On July 3, the American Society of Addiction Medicine (ASAM) submitted a letter to the Department of Health and Human Services (HHS) in response to its request for information (RFI) on the chronic disease of addiction.Full story -
The ASAM Weekly for July 7, 2026
From the rescheduling of cannabis and the surging prevalence of nicotine pouches like Zyn, to the structural setbacks face-to-face with the alcohol industry, our field is moving at a breakneck pace.Full story -
ASAM Welcomes Reintroduction of Bipartisan Legislation to Expand Medicare Coverage for Residential Addiction Treatment
Full story -
MASAM Supports Strong Health and Safety Regulation of Kratom Products
Full story -
The ASAM Weekly for June 30, 2026
One last commentary as EIC.Full story -
ASAM Applauds Bipartisan Legislation to Expand Access to Methadone Treatment for Opioid Use Disorder
Full story -
The ASAM Weekly for June 23, 2026
Social Media Use Trajectories and Substance Use ExperimentationFull story -
Guest Editorial – Stigma, Pity, and the Limits of Empathy
Explore the limits of empathy in healthcare. Learn how peer mentor O’Nesha Cochran’s lived experience challenges stigma and helps providers honor patient dignity.Full story -
The ASAM Weekly for June 16, 2026
Inclusion criteriaFull story -
MISAM Comments on Legislation Allowing Opioid Settlement Dollars to Fund Ibogaine Research
Full story -
The ASAM Weekly for June 9, 2026
EndtroducingFull story -
Dr. Smita Das Appointed Editor in Chief of The ASAM Weekly Newsletter
Full story -
FAQ: Medicaid Community Engagement Requirements — What New Rules Mean for Patients with a Substance Use Disorder
Full story -
The ASAM Weekly for June 2, 2026
Too much of a good thingFull story -
ASAM Statement: CMS Interim Final Rule on the Medicaid Community Engagement Requirement
Full story -
Guest Editorial – Using Human-in-the-Loop AI to Understand Stigma During the Deployment of Addiction Evidence-Based Practices in the HEALing Communities Study
Medications for opioid use disorder (MOUD), and overdose education and naloxone distribution (OEND), are among the most supported evidence-based practices (EBPs) in addiction medicine. Yet the real-world deployment of those EBPs at scale in diverse communities remains limited. Research shows that stigma toward these EBPs, toward people who use drugs or people receiving MOUD, plays a significant role in limiting the deployment and use of these EBPs in communities impacted by the opioid crisis.Full story -
The ASAM Weekly for May 26, 2026
Too much of a good thingFull story -
MASAM Supports Proposed Legislation Adding Methadone to the PMP
Full story -
The ASAM Weekly for May 19, 2026
Communication might just be the most valuable tool we have.Full story